In amongst a clutch of discontinued phase 3 programmes in Roche's fourth-quarter results update was the news that it has stopped a study of AKT inhibitor ipatasertib as a treatment for first-line ...

IPL 2025 M68: SRH vs KKR - TATA IPL Green Dot Balls of the Match - Jaydev Unadkat ...